organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
ºÚÁÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Articles published in Epidemiology: ºÚÁÏÍø have been cited by esteemed scholars and scientists all around the world. Epidemiology: ºÚÁÏÍø has got h-index 22, which means every article in Epidemiology: ºÚÁÏÍø has got 22 average citations.
Following are the list of articles that have cited the articles published in Epidemiology: ºÚÁÏÍø.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|---|
Total published articles |
40 | 50 | 61 | 62 | 31 | 20 | 29 | 51 | 66 |
Research, Review articles and Editorials |
17 | 40 | 36 | 15 | 17 | 12 | 0 | 0 | 0 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
0 | 2 | 7 | 16 | 2 | 0 | 0 | 0 | 0 |
Conference proceedings |
0 | 5 | 0 | 0 | 0 | 0 | 47 | 64 | 61 |
Citations received as per Google Scholar, other indexing platforms and portals |
413 | 486 | 526 | 526 | 480 | 428 | 271 | 226 | 181 |
Journal total citations count | 3849 |
Journal impact factor | 10.58 |
Journal 5 years impact factor | 10.09 |
Journal cite score | 10.22 |
Journal h-index | 22 |
Journal h-index since 2019 | 18 |
The effect of peripheral blood eosinophilia on inflammatory markers in asthmatic patients with lower respiratory tract infections |
|
| | | |
Dissemination and Implementation Science |
|
| | | |
A review of the sampling methodology used in studies evaluating the effectiveness of risk minimisation measures in Europe |
|
| | | |
Antibiotic Resistance Creating New Epoch |
|
| | | |
Opportunistic Diseases as a Consequence of HIV/AIDS |
|
| | | |
Effect of European Medicines Agency's regulatory measures on nimesulide utilization in Portugal |
|
| | | |
Risk Management for the 21st Century: Current Status and Future Needs |
|
| | | |
SNP Association Mapping across the Extended Major Histocompatibility Complex and Risk of B-Cell Precursor Acute Lymphoblastic Leukemia in Children |
|
| | | |
Association of Gel-Forming Mucins and Aquaporin Gene Expression With Hearing Loss, Effusion Viscosity, and Inflammation in Otitis Media With Effusion |
|
| | | |
Adaptation for Regulatory Application: A Content Analysis of FDA Risk Evaluation and Mitigation Strategies Assessment Plans (2014–2018) Using RE-AIM |
|
| | | |
Genetic Epidemiology of Breast Cancer in Latin America |
|
| | | |
Fetal growth and body size genes and risk of childhood acute lymphoblastic leukemia |
|
| | | |
Pre/post effectiveness evaluation of updated additional risk minimisation measures for an orphan disease: Myozyme (alglucosidase alfa) Safety Information Packet |
|
| | | |
HLA-DP genetic variation, proxies for early life immune modulation and childhood acute lymphoblastic leukemia risk |
|
| | | |
Linking process indicators and clinical/safety outcomes to assess the effectiveness of abatacept (ORENCIA) patient alert cards in patients with rheumatoid arthritis |
|
| | | |
A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution |
|
| | | |
Community pharmacists’ knowledge and perceptions on risk management plans in the Southern Region of Portugal |
|
| | | |
Variation in xenobiotic transport and metabolism genes, household chemical exposures, and risk of childhood acute lymphoblastic leukemia |
|
| | | |
Effectiveness of the golimumab educational program in ensuring healthcare professionals’ awareness of risks described in the European risk management plan |
|
| | | |
European Survey of Prescriber Understanding of Risks Associated with Retigabine |
|
| | | |
Make the best use of Scientific Research and information from our 700 + peer reviewed, ºÚÁÏÍø Journals